CNTB: LIU JEAN I discloses securities transactions

By AlphaYouPublished Oct 1, 2026Form 4

Stocks in this disclosure

Reported activity

LIU JEAN I

Reporting filer

LIU JEAN I reported Grant or award in Connect Biopharma Holdings Ltd: 8984 units of Ordinary Shares, dated 2026-09-30. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 1, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Ordinary Shares	LIU JEAN I	2026-09-30	A	Grant or award	8984	0	20,763	1 day	Filed terms security Title: Ordinary Shares transaction Date: 2026-09-30 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 8984 id: F1 transaction Price Per Share: 0 transaction Acquired Disposed Code: A shares Owned Following Transaction: 20763 direct Or Indirect Ownership: D

Ordinary Shares

Owner: LIU JEAN I
Date: 2026-09-30
Code: A
Action: Grant or award
Quantity: 8984
Price: 0
Following holdings: 20,763
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Ordinary Shares
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 8984
id: F1
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 20763
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
LIU JEAN I: Director.
F1: In accordance with the Connect Biopharma Holdings Limited Non-Employee Director Compensation Program, Ms. Liu elected to receive fully vested shares in lieu of cash compensation for her 2026 annual board retainers. Accordingly, the fully vested ordinary shares were granted to Ms. Liu for her service as a director during the third quarter of 2026. The number of shares received in lieu of cash was calculated by dividing the applicable value of the equity by the average closing price of our ordinary shares for the 30 days preceding September 30, 2026, rounded down to the nearest whole share.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Ordinary Shares

LIU JEAN I

2026-09-30

Grant or award

8984

20,763

1 day

Filed terms

security Title: Ordinary Shares
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 8984
id: F1
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 20763
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

LIU JEAN I: Director.

F1: In accordance with the Connect Biopharma Holdings Limited Non-Employee Director Compensation Program, Ms. Liu elected to receive fully vested shares in lieu of cash compensation for her 2026 annual board retainers. Accordingly, the fully vested ordinary shares were granted to Ms. Liu for her service as a director during the third quarter of 2026. The number of shares received in lieu of cash was calculated by dividing the applicable value of the equity by the average closing price of our ordinary shares for the 30 days preceding September 30, 2026, rounded down to the nearest whole share.